Long Non-coding RNA RP11-552M11.4 Favors Tumorigenesis and Development of Cervical Cancer Via Modulating MiR-3941/ATF1 Signaling
Overview
Authors
Affiliations
As one of the most aggressive malignancies, cervical cancer (CC) which mainly affects females has high risks of relapse and death. Long non-coding RNA (lncRNA) RP11-552M11.4 is verified to promote the progression of ovarian cancer; nevertheless, its role and the probable molecular mechanisms in CC remain unclear until the present study. Herein, we unveiled that the expression of lncRNA RP11-552M11.4 tested by qRT-PCR was enhanced in tumor tissues compared with the para-carcinoma tissues and related to FIGO Stage, lymph node metastasis, vascular invasion and distant metastasis in CC. Additionally, CC patients with high lncRNA RP11-552M11.4 level suffered from poor clinical outcomes. Moreover, silenced lncRNA RP11-552M11.4 restrained cell proliferation, migration and invasion in CC cells. Subsequently, the mechanistic studies revealed that lncRNA RP11-552M11.4 functioned as a ceRNA of ATF1 in CC by acting as the endogenous sponge for miR-3941, which was identified as a tumor suppressor in CC. Moreover, both miR-3941 inhibition and ATF1 overexpression restored the impacts of inhibited lncRNA RP11-552M11.4 on cellular processes in CC cells. Our observations elucidated the carcinogenic role of lncRNA RP11-552M11.4 in CC was mediated through miR-3941/ATF1 axis, giving a new insight into the effective target for the treatment and prognosis of cervical cancer.
Han C, Gao H, Li F, Lin L, Qian M, Feng L Cell Biochem Biophys. 2025; .
PMID: 39948288 DOI: 10.1007/s12013-025-01673-x.
Patel D, Thankachan S, Sreeram S, Kavitha K, Kabekkodu S, Suresh P Mol Biol Rep. 2025; 52(1):110.
PMID: 39775991 DOI: 10.1007/s11033-024-10215-2.
Cao Y, Peng Y, Tang Y J Gynecol Oncol. 2024; 36(1):e11.
PMID: 38991944 PMC: 11790996. DOI: 10.3802/jgo.2025.36.e11.
MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis.
Rezaee A, Ahmadpour S, Jafari A, Aghili S, Tamehri Zadeh S, Rajabi A Front Oncol. 2023; 13:1215194.
PMID: 37854681 PMC: 10580988. DOI: 10.3389/fonc.2023.1215194.
Basera A, Hull R, Demetriou D, Bates D, Kaufmann A, Dlamini Z Microorganisms. 2022; 10(9).
PMID: 36144454 PMC: 9501168. DOI: 10.3390/microorganisms10091852.